<?xml version="1.0" encoding="UTF-8"?><ns2:project xmlns:ns1="http://gtr.rcuk.ac.uk/gtr/api" xmlns:ns2="http://gtr.rcuk.ac.uk/gtr/api/project" xmlns:ns3="http://gtr.rcuk.ac.uk/gtr/api/fund" xmlns:ns4="http://gtr.rcuk.ac.uk/gtr/api/person" xmlns:ns5="http://gtr.rcuk.ac.uk/gtr/api/project/outcome" xmlns:ns6="http://gtr.rcuk.ac.uk/gtr/api/organisation" ns1:created="2026-06-03T15:52:43Z" ns1:href="http://gtr.ukri.org/gtr/api/projects/F04CE383-BA9A-424A-A311-0EB34AEEC041" ns1:id="F04CE383-BA9A-424A-A311-0EB34AEEC041"><ns1:links><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/5F757471-288A-4A3C-8E66-E5C76C12C99C" ns1:rel="LEAD_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/5A29B5E6-D772-442D-9D73-4EBC54CF754B" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/5F757471-288A-4A3C-8E66-E5C76C12C99C" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:end="2021-08-30T23:00:00Z" ns1:href="http://gtr.ukri.org/gtr/api/funds/1A0EB7D7-8FB9-4454-8EBC-1D32D9C8EFAC" ns1:rel="FUND" ns1:start="2019-08-31T23:00:00Z"/></ns1:links><ns2:identifiers><ns2:identifier ns2:type="RCUK">511653</ns2:identifier></ns2:identifiers><ns2:title>University of Warwick and AstraZeneca UK Limited</ns2:title><ns2:status>Closed</ns2:status><ns2:grantCategory>Knowledge Transfer Partnership</ns2:grantCategory><ns2:leadFunder>Innovate UK</ns2:leadFunder><ns2:abstractText>To apply Solid-State NMR crystallography to provide better quality products and improved manufacturing processes for disordered active pharmaceutical ingredients such as hydrates.</ns2:abstractText></ns2:project>